RxDoctor Payments Data

Jeremiah Havins

Interventional Cardiology · Hewitt, TXNPI 1427217009

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.6% of the total across 372 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,898 and has fallen 97.9% since, to $62 in 2025. That places this record below the midpoint for interventional cardiology clinicians in TX, where the typical reported total is $9,094.

$10,422in general payments, 2019–2025

Across 372 payments — averaging $28.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Biotronik Inc.$1K
  • Organogenesis Inc.$800
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$605
  • Johnson & Johnson$502
  • Novartis$391
  • plus $4K from 34 others

What the payments were for

  • Speaking & faculty fees$8008%
  • Food & beverage$9,55092%
  • Education$721%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,422 in reported general payments places this provider in the 50th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium14$142

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Hewitt

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →